Markets:

Overview

News

Currencies

International

Treasuries

Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

15.42 +1.04 (+7.23%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Summit Therapeutics Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Acurx Pharmaceuticals Ibezapolstat Targets Front-Line Opportunity After Pfizer Fails To Reach CDI Trial Primary Endpoint (NASDAQ: ACXP)

March 07, 2022

Via AB Newswire

80 Biggest Movers From Yesterday ↗

March 02, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 01, 2022

Gainers Organogenesis Holdings (NASDAQ:ORGO

Via Benzinga

88 Biggest Movers From Yesterday ↗

February 25, 2022

Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 26, 2022

Gainers Vaccinex (NASDAQ:VCNX) shares moved upwards by 30.4% to $1.33 during Wednesday's pre-market session. The market value of their outstanding shares is at $40.9...

Via Benzinga

Acurx Pharmaceuticals’ Ibezapolstat Takes Center Stage After Summit Therapeutics Misses Phase 3 C.Diff Trial Endpoints (NASDAQ: ACXP)

January 03, 2022

Via AB Newswire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Summit Therapeutics Inc. with Losses of $100,000 to Contact the Firm

December 28, 2021

From The Schall Law Firm

Via Business Wire

Mid-Afternoon Market Update: Dow Tumbles 500 Points; Bluerock Residential Growth Shares Spike Higher ↗

December 20, 2021

Toward the end of trading Monday, the Dow traded down 1.42% to 34,862.49 while the NASDAQ fell 1.38% to 14,960.51. The S&P also fell, dropping 1.34% to 4,558.87. The U.S. has...

Via Benzinga

65 Biggest Movers From Yesterday ↗

December 21, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock...

Via Benzinga

Summit Therapeutics' Infection Candidate Flunks In Head-To-Head Trial ↗

December 20, 2021

Summit Therapeutics Inc (NASDAQ: SMMT) shares are trading lower after disappointing results from the Phase 3 Ri-CoDIFy study of ridinilazole for C. difficile...

Via Benzinga

Selloff Deepens as Covid-19 Casts Shadow Over Holidays ↗

December 20, 2021

This morning's selloff has deepened by midday, as investors assess how the rapidly spreading Covid-19 omicron variant could impact the holiday season.

Via Talk Markets

Mid-Day Market Update: Crude Oil Drops Over 5%; Society Pass Shares Jump ↗

December 20, 2021

Midway through trading Monday, the Dow traded down 1.78% to 34,735.33 while the NASDAQ fell 1.43% to 14,952.69. The S&P also fell, dropping 1.59% to 4,547.26. The U.S. has the...

Via Benzinga

38 Stocks Moving In Monday's Mid-Day Session ↗

December 20, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE: CANF...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Carnival Reports Downbeat Q4 Revenue ↗

December 20, 2021

Following the market opening Monday, the Dow traded down 1.58% to 34,806.55 while the NASDAQ fell 1.40% to 14,956.74. The S&P also fell, dropping 1.40% to 4,555.91. The U.S....

Via Benzinga

AcurX Pharmaceuticals’ C. Difficile Drug Candidate Could Fetch $800 Million On A Peer Comparison Basis (NASDAQ: ACXP)

October 20, 2021

Via AB Newswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 22, 2021

Gainers Regencell Bioscience (NASDAQ:

Via Benzinga

Mid-Afternoon Market Update: Dow Surges Over 400 Points; Stitch Fix Shares Spike Higher ↗

September 22, 2021

Toward the end of trading Wednesday, the Dow traded up 1.28% to 34,353.01 while the NASDAQ rose 1.07% to 14,904.89. The S&P also rose, gaining 1.15% to 4,404.34. The U.S. has...

Via Benzinga

Topics Stocks

50 Biggest Movers From Yesterday ↗

September 23, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement from management that the company entered into a...

Via Benzinga

32 Stocks Moving In Wednesday's Mid-Day Session ↗

September 22, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; General Mills Reports Upbeat Q1 Results ↗

September 22, 2021

Following the market opening Wednesday, the Dow traded up 1.01% to 34,262.50 while the NASDAQ rose 0.63% to 14,839.63. The S&P also rose, gaining 0.82% to 4,389.97. The U.S....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 22, 2021

Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 33.15% to $5.06 during Wednesday's pre-market session. The market value of their outstanding shares is at $77.8...

Via Benzinga

FDA Not In Favor Of Summit Therapeutics' Endpoint Change To Pivotal Infection Trials ↗

September 22, 2021

Summit Therapeutics Inc (NASDAQ: SMMT) announced that the FDA disagrees with its proposed change to the primary endpoint in Phase 3 Ri-CoDIFy studies. In a regulatory...

Via Benzinga

35 Stocks Moving In Wednesday's Mid-Day Session ↗

May 19, 2021

Gainers Advaxis, Inc. (NASDAQ: ADXS) shares jumped 43.1% to $0.6943 after jumping over 14% on Tuesday. MoSys, Inc. (NASDAQ: MOSY) shares gained 32% to $5.00. Reata...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

Summit Therapeutics Stock Surges Higher But Slams Into A Wall Of Resistance ↗

May 18, 2021

Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) stock had...

Via Benzinga

Summit Therapeutics Unveils Preclinical Candidate For Multidrug-Resistant Infections ↗

May 18, 2021

Summit Therapeutics Inc (NASDAQ: SMMT) has selected a new preclinical candidate, SMT026738 (SMT-738), for development against multidrug-resistant infections,...

Via Benzinga

50 Biggest Movers From Yesterday ↗

May 20, 2021

Gainers MoSys, Inc. (NASDAQ: MOSY) shares jumped 44.1% to settle at $5.46 on Wednesday. Lianluo Smart Limited (NASDAQ: LLIT) gained 24.6% to settle at $9.22. Reata...

Via Benzinga

58 Biggest Movers From Yesterday ↗

May 19, 2021

Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results. Ultralife Corporation (NASDAQ: ULBI)...

Via Benzinga

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO ↗

May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...

Via Benzinga

58 Biggest Movers From Yesterday ↗

May 18, 2021

Gainers Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday. Nuvve Holding Corp. (NASDAQ: NVVE) shares jumped 30.9% to close at $10.80 on...

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.